At Viritis Ltd, we believe the future of antiviral medicine lies in developing a platform that can be rapidly adapted to combat a wide range of viruses, rather than a single target. That’s why we are pioneering a next-generation antisense-based platform for the rapid development of antiviral drugs. Our innovative technology targets all strains of a given virus, providing a scalable and precise solution to both current and emerging viral threats.

Our platform combines AI-driven algorithms with a patented molecular design that binds specifically to viral genetic material. Once attached, it activates the cell’s innate defense mechanisms, which degrade the virus without harming the host. After completing its function, the molecule naturally disintegrates within hours, leaving no harmful residues.